========================================================================
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
----------------------------
FORM 10-QSB/A
AMENDMENT NO. 1
(Mark One)
/x/ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 1996
OR
/ / TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the transition period from ---------- to ----------------
Commission File Number: 1-11765
MEDJET INC.
(Exact name of Small Business Issuer as Specified in its Charter)
DELAWARE 22-3283541
(State or Other Jurisdiction (I.R.S. Employer Identification No.)
of Incorporation or Organization)
1090 KING GEORGES POST ROAD, SUITE 301
EDISON, NEW JERSEY 08837
(Address of Principal Executive Offices)
(908) 738-3990
(Registrant's Telephone Number, Including Area Code)
----------------------------------------------------
(Former Name, Former Address and Former Fiscal
Year, if Changed Since Last Report
Check whether the issuer (1) has filed all reports required to be
filed by Section 13 or 15(d) of the Exchange Act during the past 12 months
(or for such shorter period that the registrant was required to file such
reports), and (2) has been subject to such filing requirements for the past
90 days. [ ] Yes [ X ] No
Common Stock, par value $.001 per share, outstanding as of September
13, 1996: 3,682,455 shares.
Units, each consisting of one share of Common Stock and one warrant to
purchase one share of common stock outstanding as of September 13, 1996:
1,232,143 Units
Transitional Small Business Disclosure format: [ ] Yes [ X ] No
========================================================================
<PAGE>
This Amendment No. 1 to the Quaterly Report on Form 10-QSB of Medjet
Inc. (the "Company") is being filed solely for the purpose of filing
Exhibit 27, the Financial Data Schedule.
<PAGE>
Item 6. EXHIBITS.
(a) EXHIBITS
27. Financial Data Schedule
<PAGE>
SIGNATURE
---------
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.
Dated: November 5, 1996
MEDJET INC.
-----------------------------------
(Registrant)
/s/ Eugene I. Gordon
-----------------------------------
Eugene I. Gordon
President and Chief Executive Officer
/s/ Thomas M. Handschiegel
------------------------------------
Thomas M. Handschiegel
Chief Financial Officer and
Chief Accounting Officer
<PAGE>
EXHIBIT INDEX
Sequentially
No. Description Numbered Pages
- --- ----------- --------------
27. Financial Data Schedule
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the June 30,
1996 (unaudited) financial statements of Medjet Inc. and is qualified in its
entirety by reference to such financial statements.
</LEGEND>
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> DEC-31-1996
<PERIOD-END> JUN-30-1996
<CASH> 61,046
<SECURITIES> 0
<RECEIVABLES> 2,477
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 64,279
<PP&E> 86,517
<DEPRECIATION> 63,811
<TOTAL-ASSETS> 578,130
<CURRENT-LIABILITIES> 1,047,551
<BONDS> 615,000
0
0
<COMMON> 2,450
<OTHER-SE> (469,421)
<TOTAL-LIABILITY-AND-EQUITY> 578,130
<SALES> 0
<TOTAL-REVENUES> 0
<CGS> 0
<TOTAL-COSTS> 0
<OTHER-EXPENSES> 455,382
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 16,030
<INCOME-PRETAX> (471,412)
<INCOME-TAX> 151
<INCOME-CONTINUING> (471,563)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (471,563)
<EPS-PRIMARY> (.19)
<EPS-DILUTED> (.19)
</TABLE>
